Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

0.4000 -0.0100 (-2.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 916,467
Open 0.4100
Bid (Size) 0.4010 (10)
Ask (Size) 0.4135 (991)
Prev. Close 0.4100
Today's Range 0.4000 - 0.4200
52wk Range 0.3900 - 2.089
Shares Outstanding 198,755,831
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ocugen CSO to Participate in 4th Annual Gene Therapy for Ophthalmic Disorders Conference
From Ocugen
Via GlobeNewswire
Ocugen to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
From Ocugen
Via GlobeNewswire

Performance

YTD
-68.00%
-68.00%
1 Month
-12.97%
-12.97%
3 Month
-23.72%
-23.72%
6 Month
-51.43%
-51.43%
1 Year
-80.30%
-80.30%

More News

Read More
A Preview Of Ocugen's Earnings
Via Benzinga
Can Pat Toomey Save Ocugen (OCGN) Stock?
Via InvestorPlace
Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board
From Ocugen
Via GlobeNewswire
Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023
From Ocugen
Via GlobeNewswire
Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)
From Ocugen
Via GlobeNewswire
Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023
From Ocugen
Via GlobeNewswire
Ocugen (OCGN) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Ocugen Provides Business Update with Second Quarter 2023 Financial Results
From Ocugen
Via GlobeNewswire
Ocugen to Host Conference Call on Tuesday, August 22 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2023 Financial Results
From Ocugen
Via GlobeNewswire
3 Millionaire-Maker Growth Stocks to Buy Before the Window
Via InvestorPlace
7 Biotech Stocks to Sell in July
Via InvestorPlace
7 Doomed Growth Stocks Destined for Disaster
Via InvestorPlace
Ocugen CEO & CSO to Present at 41st Annual AAPI Convention and Scientific Assembly
From Ocugen
Via GlobeNewswire
Ocugen And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga
Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders
From Ocugen
Via GlobeNewswire
Ocugen, Inc. Announces Business Advisory Board
From Ocugen
Via GlobeNewswire
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
Via The Motley Fool
5 Investors Betting Big on Ocugen (OCGN) Stock Right Now
Via InvestorPlace
Crude Oil Rises 2%; Kohl's Reports Surprise Q1 Profit
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Down 1%; US Crude Oil Inventories Decline Last Week
Via Benzinga
Why Is Apexigen (APGN) Stock Up 31% Today?
Via InvestorPlace
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.